| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Workplace Communication > Five Hidden Traps in Meetings |
|
Just Other Articles - Five Hidden Traps in Meetings
If you have sat through a few bad meetings, you must have experienced the
following traps. Here they are and how to fix them. 1) People think they are experts. Many people tell me According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product that they know how to hold a meeting. Actually, all they do is
host a party. They invite guests, provide treats, and preside over a conversation.
People talk. People eat. And not ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hing happens. Or, if they somehow manage to reach
an agreement, no one implements it. What to do: Learn how to lead a real meeting. Schedule a workshop or buy a book. When result lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s really matter, hire a facilitator. Recognize that there are modern tools
that help people make methodical progress toward results. These tools are practical
and easy to use. Of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe course, you have to know what they are in order to use them.
Call me (714-528-1300) for details. 2) People think they are inspiring. Many people believe that long-winded announcem d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ents impress others. Actually, it's
the opposite. A long lecture quickly becomes a boring (and sometimes offensive)
harangue. Why? Most employees want an active role in contributi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng to the business,
and thus listening to a speech feels like a waste of time. What to do: Design meetings that give the attendees opportunities to contribute. Plan questions tha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t direct thinking toward the results that you want. Use activities
that help people make decisions. Distribute announcements in letters, memos, or E-
mails. Or, if you must use a m nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically eeting, keep announcements brief (less than a few
minutes). 3) People think others agree with them. Many people rely on nods, smiles, and eye contact to measure acceptance. Actual and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ly,
most employees will do anything to appease a boss. And if the boss seems to be
upset, the employees will become even more agreeable. Then, once the meeting
ends, the employe ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi es will do one of three things: 1) forget the lecture, 2) ignore the
message, or 3) sabotage the idea. What to do: Conduct meetings by a process that everyone considers to be fair. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Use
consensus to reach agreements and make decisions. People will accept decisions
that they helped make. 4) People think others are clairvoyant. Many people call meetings with dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod out an agenda expecting that everyone will arrive
sharing their vision for what needs to be done. Actually, everyone brings their
private hopes, fears, and vision to the meeting. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Without a clear agenda, the result is
something between chitchat and chaos, depending upon the complexity of the
issue. Note: A vague agenda, such as a list of topics, is almost tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen as useless as no agenda. What to do: Write out your goal for the meeting. Then prepare an agenda that is so complete someone else could use it to run the meeting without you. Speci t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel fy each
step and provide a time budget. Send the agenda at least a day before the meeting
so that the attendees can use it to prepare. Call key participants before the meeting
t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o check if they have questions or want to talk about the agenda. 5) People think meetings are necessary. Many people respond to every emergency, surprise, or twitch by calling a mee y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ting.
Actually, a meeting is a special (and expensive) process. It should be used only to
obtain results that require the efforts of a group of people working as a team. A
meeti . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ng is NOT a universal cure for everything. Meetings held for the wrong
reasons, waste everyone's time. What to do: Challenge every meeting for its ability to earn a profit for your elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip business.
That is, make sure the value of the results is greater than the cost of holding a
meeting. If any other activity can accomplish the same result, use that other activity tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:10 Ways To Come Out A Winner In An Interview Forward Thinkers Stay Ahead of the Curve What if You are Not Good in Public Relations?
|